Consultant Clinical Biochemist

Slides:



Advertisements
Similar presentations
A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.
Advertisements

National Institute for Health and Clinical Excellence.
Use of clinical laboratory databases to enable early identification of patients at highest risk of developing end- stage kidney disease Dr David Kennedy.
1.Royal College of Obstetricians and Gynaecologists. The Green Top Guidelines Number 21: The management of tubal pregnancy. (Online). Available from:
Chronic kidney disease Mr James Hollinshead Public Health Analyst East Midlands Public Health Observatory (EMPHO) UK Renal Registry 2011 Annual Audit Meeting.
Retrospective Audit of Delayed Diagnosis of Hydronephrosis in Acute Kidney Injury John Dreisbach Radiology ST3 West of Scotland Deanery Acknowledgements:
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Expert Systems in Renal Disease Kent Renal ServiceUniversity of KentSalford Hospital Chris Farmer Bernhard Klebe Jean IrvingDonal O’Donoghue Paul StevensRoger.
UKRR Dataset v4.1 How does it fit with the UKRDC ACTIONS IN YOUR RENAL UNIT TO IMPLEMENT THE NEW DATASET UK RENAL REGISTRY 2015 INFORMATICS MEETING: DATA.
“Do Once and Share” Feedback from the Renal Team B Stribling, K Harris, A Keogh, J Medcalf.
An Introduction to Acute Kidney Injury (AKI)
Raghavan Murugan, MD, MS, FRCP Associate Professor of Critical Care Medicine, and Clinical & Translational Science Core Faculty, Center for Critical Care.
NOROVIRUS OUTBREAK IN A UNIVERSITY TEACHING HOSPITAL O Meara M, O Connor M, Dept of Public Health, Dr. Steevens Hospital Background On March 7th 2006,
Intelligent Targets for Depression Dr Adrian Jones, ACOS Dr Alys Cole King, Consultant Liaison Psychiatrist Dr Teresa Ching, Consultant Respiratory Physician.
South West Hepatitis C Needs Assessment Dr Maya Gobin Health Protection Services (South West)
Acute Kidney Injury. 100,000 deaths are year are associated with acute kidney injury. (NCEPOD 2009)
BACKGROUND Acute Kidney Injury (AKI) is common, with an incidence of one in five emergency admissions in the UK and up to 100,000 deaths each year in hospital.
Physical Health and People with a Severe Mental Illness
Clair Huckerby Pharmaceutical Public Health Team Dudley CCG
l asthma nnovation in quality improvement of care in children
An AKI project for critically ill cancer patients
NHS RightCare scenario: Getting the dementia pathway right
NW regional audit of CA125 requesting in primary care
The LIVES Sub-analysis
Patient Safety in Surgical Care Reducing Patient Harm due to
Right Care Deep Dives NEW Devon CCG Blood Disorders.
Hypertension November 2016
Outcomes in AKI, the national audit
NDA – THE LATEST DATA Prof Roger Gadsby MBE FRCGP Honorary Associate Clinical Professor , WMS GP Clinical Lead National Diabetes Audit.
Dementia Learning Session
AKI in critically ill cancer patients:
National Diabetes Audit – An Overview
Outcomes from the Secondary Care COPD Audit 2014
Introduction Methods Results Conclusions References
Effect of Acute Kidney Injury on Chronic Kidney Disease Progression and Proteinuria: Initial Results from a Pilot Study Horne K1, Scott R1, Packington.
Lancet. 2017 Aug 5;390(10094): doi: /S (17) Epub 2017 May 25.
Test.
Outcomes from the Pulmonary Rehabilitation COPD Audit 2015
Integrating Clinical Pharmacy into a wider health economy
PREDICTIVE VALUE OF CHRONIC KIDNEY DISEASE (CKD) IN ACUTE KIDNEY INJURY (AKI) PRESENTATION IN AN INTENSIVE CARE UNIT (ICU) OF A LOCAL HOSPITAL. José María.
Test.
National Clinical Director (Renal)
Annual General Meeting
Flu epidemiology in Scotland – season 2017/18
Acute Kidney Injury (AKI)
Objectives Early initiation of continuous renal replacement therapy
Simon Sawhney, Simon D. Fraser  Advances in Chronic Kidney Disease 
National Cancer Diagnosis Audit
2018 Annual Data Report Volume 1: Chronic Kidney Disease
Transforming Maternity Services Mini-Collaborative
“the national perspective” Medical Director of the UK Renal Registry
Background 30% of acute hospital days used by patients in the last year of life 75% of people will be admitted to hospital in the last year of life Location.
Simon Sawhney, Simon D. Fraser  Advances in Chronic Kidney Disease 
BACKGROUND The optimal timing of RRT initiation in critically ill patients with AKI is still uncertain No consensus to guide clinical practice of acute.
The impact of an integrated Renal Supportive Care Service on Symptom Burden, Advanced Care Planning and Place of Death for patients with Advanced Chronic.
Management of Outbreaks of Acute Respiratory Illness in Care Homes Out of Season and In Season Other areas: Where the home feels that their resident needs.
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
Principal recommendations
Critical Care Outreach Medway
Trainers facing learner issues
General Imaging Information
Ambitions and Trajectories
Hypertension November 2016
New Advice for AKI Detection and Prevention in Primary Care
Calculate Well’s score for PE (BOX1)
Cardiff and Vale UHB Dr Graham Shortland
Primary care and AKI test results:
Dr Donal O’Donoghue National Clinical Director for Kidney Care
The impact of an integrated Renal Supportive Care Service on Symptom Burden, Advanced Care Planning and Place of Death for patients with Advanced Chronic.
Presentation transcript:

Consultant Clinical Biochemist Audit of Acute Kidney Injury Stage 2 and Stage 3 alerts in Primary Care patients Jane Oakey Consultant Clinical Biochemist

Acute Kidney Injury NHS England Patient Safety Alert to implement AKI alerts in Secondary Care by March 2015 using the national algorithm The algorithm compares the current creatinine result to a baseline creatinine (lowest creatinine in the last 7 days or the median creatinine over the previous 8-365 days) Early detection of AKI using Primary Care creatinine results is vital for improving outcomes Think Kidneys provided guidance information and recommended response times for AKI alerts in Primary Care

AKI Alerts in Primary Care Approximately 65% of AKI starts in the community Alerting mechanisms also required for creatinine results from Primary Care patients Recommended response times to AKI alerts for adults in Primary Care: Alert Stable clinical context Context of acute illness AKI Stage 1 Consider clinical review ≤ 72 hours of alert to confirm/refute AKI Consider clinical review ≤ 24 hours of alert. Likely AKI Stage 1 AKI Stage 2 Consider clinical review ≤ 24 hours of alert to confirm/refute AKI Consider clinical review ≤ 6 hours of alert. Likely AKI Stage 2 AKI Stage 3 Consider clinical review ≤ 6 hours of alert. If AKI confirmed, consider admission Consider immediate admission. Likely AKI Stage 3 Recommended response times to AKI alerts for adults in Primary Care2 Consider drugs that maybe harmful to kidneys, obstruction, hydration and infection. If there are AKI risk factors (e.g. poor oral intake/fluid output, hyperkalaemia, known CKD stages 4-5, past history of AKI, other comorbidities) consider earlier review.   www.thinkkidneys.nhs.uk/aki Selby et al, PLoS One (2012)

Introducing Primary Care AKI alerts in East Lancashire GP educational sessions provided AKI alerts reported with all Primary Care creatinine results from April 2017 Two CCGs Population: 530 000 82 GP practices All Primary Care samples analysed at the Blackburn laboratory 1100 renal profile requests received every weekday from Primary Care

Audit Aim and Standards Aim: To determine the follow up and patient outcomes following an AKI Stage 2 or 3 alert within Primary Care in East Lancashire Standard Source 1 New occurrences of AKI 2 and 3 alerts should be telephoned RCPath The communication of critical and unexpected pathology results (2017) 2 Patients with AKI 2 or 3 alerts should be reviewed within 24 hours or 6 hours respectively (earlier if patient is acutely unwell). Think Kidneys There is currently limited information on the response to an AKI alert or outcomes for Primary Care patients

Audit Methodology All Primary Care AKI 2 and 3 alerts from 1st January – 30th April 2018 were extracted from the LIMS Each patient’s record was reviewed: Was the result telephoned? What action was taken following the phone call? What was the mortality rate at 30 days?

Primary Care AKI alerts (Jan-April 2018) Percentage of total No. of patients Male % (n) Median age (range) AKI 1 377 0.43 370 AKI 2 56 0.06 48 46% (22) 77 (35-97) AKI 3 37 0.04 34 56% (19) 70 (20-88) Total number of Primary Care AKI alerts = 87247

Standard 1: AKI 2 and 3 alerts should be telephoned to Primary Care   AKI 2   AKI 3 No. of alerts 60 37 Telephoned to the GP practice or Out of Hours Service (n (%) 59 (98%) 33 (89%)

Follow up- AKI Stage 2

Standard 2: Patients with AKI 2 alerts should be reviewed within 24 hours n=48 patients 58% of patients were admitted to hospital immediately Median time to hospital admission was 9 hours

Follow up of patients with AKI 2 alerts Patients admitted to hospital (30/48) Median time from phone call to admission = 9 hours 4 patients progressed to an AKI 3 alert on admission sample Repeat blood samples collected at GP surgery (7/48) 3 patients admitted the next day (1 progressed to AKI 3 alert on the repeat blood sample) No admission/repeat sample (8/48) None were subsequently admitted with AKI (up to 31.08.18) No further action required (3/48) 1 post pregnancy 2 patients were known Chronic Kidney Disease patients 1 patient had AKI3 on the repeat sample CKD patient – the alert did not suggest AKI based on previous results and history

Follow up- AKI Stage 3

Standard 2: Patients with AKI 3 alerts should be reviewed within 6 hours n=34 patients 62% of patients were admitted to hospital immediately Median time to hospital admission was 7 hours

Follow up of patients with AKI 3 alerts Patients admitted to hospital (21/34) Median time from phone call to admission = 7 hours No admission/repeat sample (3/34) None were subsequently admitted with AKI (up to 31.08.18) No further action required (10/34) 9 patients were known Chronic Kidney Disease patients 1 patient was receiving palliative care No admission/repeat sample: 1 patient had a repeat blood sample collected 17 days later 2 patients attended the Hepatology Clinic approximately 2 weeks later CKD – the alert did not suggest AKI based on history and previous results Hepatology Clinic patients - Repeat renal results confirmed that the renal function had improved and the creatinine was similar to previous baseline results.

30 day mortality rate in Primary Care patients with AKI alerts Wales study looking at Primary Care has reported a 90 day mortality rate of 15.4% for all stages of alert. The renal registry data is adjusted for age and sex

Primary Care AKI Alerts- Summary 95% of AKI 2 and 3 alerts were telephoned by the laboratory to Primary Care Most patients were admitted to hospital within 24 hours of the alert phone call (58% and 62% for AKI 2 and 3 respectively) Five patients progressed from AKI Stage 2 to AKI Stage 3 (four patients had already been admitted) Thirteen patients had alerts but did not have AKI Eleven patients were not admitted and had no repeat blood sample; none were subsequently admitted to hospital with AKI (to date) The mortality rates in Primary Care patients with AKI alerts (6% and 15% for AKI 2 and 3) were lower than the nationally reported mortality rates from the Renal Registry (25.4% and 27.3% for AKI 2 and 3)

Conclusions Guidance and educational sessions for Primary Care is essential for the successful implementation of AKI alerts Phoning all AKI 2 and 3 alerts to Primary Care is ensuring rapid review and admission to hospital of the most appropriate patients In our population, detection of AKI in Primary Care reduced the mortality rate (particularly for patients with AKI Stage 2) Wider audit of outcomes following AKI alerting in Primary Care is required. Review of guidance including targets for clinical review Think Kidneys Guidance has been useful for our population - Are the clinical review targets realistic or required?

Questions